share_log

DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call

DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call

DaVita公司安排於2024年第二季度進行投資者電話會議看漲
德維特 ·  07/18 12:00

DENVER, July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 6, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.

德維特公司(NYSE:DVA)於2024年7月18日宣佈,該公司計劃於2024年8月6日(星期二)下午5點東部時間舉行季度電話會議,以討論第二季度的業績。該公司計劃在同一天市場收盤後公佈其結果。

This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:

這次電話會議也將通過DaVita投資者關係網頁進行網絡直播,您可以按以下方式參加此次電話會議:

Tuesday, August 6, 2024
Starting at 5:00 p.m. EDT
Webcast can be accessed using this link
Dial in number: 877-918-6630
International dial in: 517-308-9042

2024年8月6日,星期二
電話會議將於美國東部時間下午5點開始。
可通過此鏈接訪問網絡直播。
撥入電話號碼:877-918-6630。
國際撥入電話號碼:517-308-9042。

When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay.

在致電時,請向運營商提供密碼“Earnings”,並提供您的姓名和公司名稱。無法聽取電話會議的投資者將能夠通過我們的網站investors.davita.com訪問重播。不提供電話重播。

About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of March 31, 2024, DaVita served approximately 258,600 patients at 3,092 outpatient dialysis centers, of which 2,665 centers were located in the United States and 427 centers were located in 12 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

關於德維特公司
DaVita(NYSE:DVA)是一家專注於改進全球患者的生命質量的醫療保健服務提供商。該公司是美國最大的腎臟護理服務提供商之一,並在臨床質量和創新方面擔當領導者已經超過20年。DaVita在慢性腎臟病的每個階段和環節爲患者提供護理,從減緩腎臟疾病的進展到幫助支持移植,從急性醫院護理到居家透析。截至2024年3月31日,DaVita在3092個門診透析中心爲約258,600名患者提供護理,其中2665箇中心位於美國,另外427箇中心位於全球12個其他國家。DaVita減少了住院、提高了患者的生存率,並協作推動腎臟護理行業採用公平和高質量的護理標準,使每個患者在任何地方都能得到最好的護理。欲了解更多信息,請訪問DaVita.com/About。

Contact Information
Investors:
IR@davita.com

聯繫信息
投資者:
IR@davita.com

big

SOURCE DaVita

SOURCE 德維特

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論